Divi's Laboratories
DIVISLABNSE

Divi's Laboratories

₹5,835.00-71.50 (1.21%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
F&O

Performance

Today’s low
5,647.50
Today’s high
5,852.50
52 week low
4,955.00
52 week high
7,071.50
Open price
5,851.00
Previous close
5,906.50
Live volume
3,60,266
Lower circuit
5,316.00
Upper circuit
6,497.00

Fundamentals

Market Cap
₹1,56,811Cr
ROE
16.12%
P/E Ratio(TTM)
63.26
EPS(TTM)
93.38
P/B Ratio
10.17
Dividend Yield
0.51%
Industry P/E
31.44
Book Value
580.60
Debt to Equity
0.01
Face Value
2

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Divi's Laboratories is a prominent global manufacturer specializing in Active Pharmaceutical Ingredients (APIs), Custom Synthesis for innovator companies, and high-quality Nutraceutical ingredients. The company's vision is to create lasting value for its stakeholders by producing superior generic APIs and custom intermediates for the global pharmaceutical and nutraceutical industries. It aims to be a responsible business, adding value through its expertise in chemistry and serving the community with diverse social initiatives for a better future. As an API-exclusive manufacturer, Divi's focuses solely on producing ingredients and does not compete with its customers by marketing the final medicine formulations. A key operational strength is its backward-integrated model, which allows the company to produce most key starting materials internally, ensuring quality and supply security. This business model has made Divi's a trusted global supplier to pharmaceutical companies across more than 100 countries, with exports making up 88% of its revenue.;
MD/CEO
Dr. Kiran S. Divi
Founded in
1990
NSE symbol
DIVISLAB
Industry

Shareholding Pattern

Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Promoters
51.88%
Foreign Institutions
20.08%
Mutual Funds
13.73%
Retail And Others
8.76%
Other Domestic Institutions
5.55%

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹1,699.90
-6.10 (0.36%)
L
    H
    28,118.1533.192.94
    ₹964.95
    -11.90 (1.22%)
    L
      H
      20,692.9562.169.12
      ₹139.50
      -3.01 (2.11%)
      L
        H
        18,975.02-116.062.35
        ₹1,427.40
        -9.00 (0.63%)
        L
          H
          16,456.17820.42.79
          Livesquawk
          Jefferies retains Buy on Divi's Laboratories with a target of ₹8,200, citing GLP and peptide CDMO scaling. Projected FY32 revenue: $600m (oral GLP) + $400m (injectable GLP); FY26–32E revenue/EPS growth ~15%/20%.
          Livesquawk
          Divi's Laboratories sees NSE block trade worth Rs. 56.5 crore. Approx. 89,698 shares traded at Rs. 6,302.5 per share.
          Livesquawk
          Divi's Laboratories executed a block trade of ~79,936 shares at Rs. 6,296. The transaction amounted to Rs. 50.3 crores on NSE.
          Livesquawk
          Divi's Laboratories reported a 30% MoM decline in CO exports. The drop raises concerns about the company's international sales performance.
          Livesquawk
          Divi's Labs plans custom synthesis projects, targeting commercial volumes by 2027. The company aims for a gross asset turnover ratio of 1.5-1.8 in 4-5 years.
          Livesquawk
          Divi's Labs expects raw material pricing and availability to remain stable for six months. The nutraceuticals segment is projected to maintain strong growth performance.
          Livesquawk
          Goldman Sachs retains 'Neutral' rating for Divis Lab, revises target price to Rs 6,050.
          2026
          11
          Feb
          Quarterly Result
          Release date
          2025
          7
          Nov
          Quarterly Result
          Release date
          6
          Aug
          Quarterly Result
          Release date

          25
          Jul
          Dividend
          Ex date
          ₹30.00
          per share

          For each share you hold, you will receive ₹30.00
          Dividend amount₹30.00 per share
          Dividend TypeFinal
          Ex Date25 Jul ‘25
          Record Date25 Jul ‘25
          Announcement date17 May ‘25

          17
          May
          Dividend
          Announced
          ₹30.00
          per share

          For each share you hold, you will receive ₹30.00
          Dividend amount₹30.00 per share
          Dividend TypeFinal
          Ex Date25 Jul ‘25
          Record Date25 Jul ‘25
          Announcement date17 May ‘25
          2024

          2
          Aug
          Dividend
          Ex date
          ₹30.00
          per share

          For each share you hold, you will receive ₹30.00
          Dividend amount₹30.00 per share
          Dividend TypeFinal
          Ex Date2 Aug ‘24
          Record Date2 Aug ‘24
          Announcement date25 May ‘24

          25
          May
          Dividend
          Announced
          ₹30.00
          per share

          For each share you hold, you will receive ₹30.00
          Dividend amount₹30.00 per share
          Dividend TypeFinal
          Ex Date2 Aug ‘24
          Record Date2 Aug ‘24
          Announcement date25 May ‘24
          Events calendar
          View upcoming events in other stocks